aTYR PHARMA INC Annual Net Income (Loss) Attributable to Parent in USD from 2013 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
aTYR PHARMA INC quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2023.
- aTYR PHARMA INC Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$16.3M, a 32.2% decline year-over-year.
- aTYR PHARMA INC Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$57.9M, a 28.5% decline year-over-year.
- aTYR PHARMA INC annual Net Income (Loss) Attributable to Parent for 2023 was -$50.4M, a 11.1% decline from 2022.
- aTYR PHARMA INC annual Net Income (Loss) Attributable to Parent for 2022 was -$45.3M, a 34.3% decline from 2021.
- aTYR PHARMA INC annual Net Income (Loss) Attributable to Parent for 2021 was -$33.8M, a 108% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)